List of works - Jennifer Connelly

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma

scientific article

ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA.

scientific article

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

scientific article

Effects of perfusion on diffusion changes in human brain tumors

scientific article published on 06 February 2013

GENO-02INTEGRATED ANALYSIS OF MOLECULAR SUBTYPES IN GLIOBLASTOMA MULTIFORME.

scientific article

Location of brain tumor intersecting white matter tracts predicts patient prognosis.

scientific article published on 16 September 2015

Longitudinal molecular trajectories of diffuse glioma in adults

scientific article published on 20 November 2019

Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy

scientific article published on September 2016

Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors

scientific article published on 28 March 2019

NI-58LOCATION OF GLIOBLASTOMA INTERSECTIING WHITE MATTER TRACTS PREDICT PATIENT PROGNOSIS AND RESPONSE TO BEVACIZUMAB PRIOR TO THERAPY.

scientific article published in November 2014

NIMG-47PATHOLOGICALLY CONFIRMED VIABLE TUMOR SURROUNDS REGIONS OF PROGRESSIVELY EXPANDING DIFFUSION-RESTRICTED NECROSIS FOLLOWING BEVACIZUMAB TREATMENT.

scientific article

NIMG-58PRELIMINARY TRENDS IN ADVANCED IMAGING RELATIVE TO STANDARD IMAGING IN SUBJECTS TREATED WITH OPTUNE.

scientific article

Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement

scientific article

Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma

scientific article

Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.

scientific article published on 04 August 2016

Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer

scientific article published on 01 June 2020

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.

scientific article published on 3 February 2013

List of works by Jennifer Connelly

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma

ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA.

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

Effects of perfusion on diffusion changes in human brain tumors

GENO-02INTEGRATED ANALYSIS OF MOLECULAR SUBTYPES IN GLIOBLASTOMA MULTIFORME.

Location of brain tumor intersecting white matter tracts predicts patient prognosis.

Longitudinal molecular trajectories of diffuse glioma in adults

Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy

Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors

NI-58LOCATION OF GLIOBLASTOMA INTERSECTIING WHITE MATTER TRACTS PREDICT PATIENT PROGNOSIS AND RESPONSE TO BEVACIZUMAB PRIOR TO THERAPY.

NIMG-47PATHOLOGICALLY CONFIRMED VIABLE TUMOR SURROUNDS REGIONS OF PROGRESSIVELY EXPANDING DIFFUSION-RESTRICTED NECROSIS FOLLOWING BEVACIZUMAB TREATMENT.

NIMG-58PRELIMINARY TRENDS IN ADVANCED IMAGING RELATIVE TO STANDARD IMAGING IN SUBJECTS TREATED WITH OPTUNE.

Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement

Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma

Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.

Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.